Lyra Therapeutics, Inc. Contracts & Agreements

Controlled Equity OfferingSM Sales Agreement, dated September 1, 2023, between Lyra Therapeutics, Inc. and Cantor Fitzgerald & Co (Filed With SEC on September 1, 2023)

Seventh Amendment to Lease, dated July 12, 2023, by and between Lyra Therapeutics, Inc. and ARE-480 Arsenal Street, LLC (Filed With SEC on July 14, 2023)

Amendment No. 1 to Ninth Amended and Restated Investor Rights Agreement, dated as of May 25, 2023, by and among Lyra Therapeutics, Inc. and the Investors named therein (Filed With SEC on May 31, 2023)

Form of Pre-Funded Warrant, together with a schedule of Pre-Funded Warrants, each dated as of May 31, 2023, issued by Lyra Therapeutics, Inc. to the Investors set forth on such... (Filed With SEC on May 31, 2023)

Form of Purchase Warrant, together with a schedule of Purchase Warrants, each dated as of May 31, 2023, issued by Lyra Therapeutics, Inc. to the Investors set forth on such... (Filed With SEC on May 31, 2023)

Securities Purchase Agreement, dated as of May 25, 2023, by and among Lyra Therapeutics, Inc. and the Investors named therein (Filed With SEC on May 31, 2023)

Registration Rights Agreement, dated as of May 25, 2023, by and among Lyra Therapeutics, Inc. and the Investors named therein (Filed With SEC on May 31, 2023)

Sixth Amendment to Lease, dated November 14, 2022, by and between Lyra Therapeutics, Inc. and ARE-480 Arsenal Street, LLC (Filed With SEC on November 16, 2022)

First Amendment to License and Collaboration Agreement, dated September 26, 2022, between Registrant and LianBio Inflammatory Limited and LianBio (Filed With SEC on November 8, 2022)

Amendment No. 3 to Lyra Therapeutics, Inc. 2022 Inducement Award Plan (Filed With SEC on November 8, 2022)

Ninth Amended and Restated Investor Rights Agreement, dated as of April 7, 2022, by and among Lyra Therapeutics, Inc. and the Investors named therein (Filed With SEC on April 13, 2022)

Form of Common Stock Purchase Warrant, together with a schedule of Warrants, each dated April 12, 2022, issued by Lyra Therapeutics, Inc. to the Investors set forth on such... (Filed With SEC on April 13, 2022)

Securities Purchase Agreement, dated as of April 7, 2022, by and among Lyra Therapeutics, Inc. and the Investors named therein (Filed With SEC on April 13, 2022)

Registration Rights Agreement, dated as of April 7, 2022, by and among Lyra Therapeutics, Inc. and the Investors named therein (Filed With SEC on April 13, 2022)

Description of Securities (Filed With SEC on March 9, 2022)

Employment Agreement between the Registrant and Corinne Noyes dated as of April 27, 2020 (Filed With SEC on March 9, 2022)

Employment Agreement between the Registrant and Pamela Nelson dated as of July 17, 2020 (Filed With SEC on March 9, 2022)

Employment Agreement between the Registrant and Robert Richard dated as of June 20, 2020 (Filed With SEC on March 9, 2022)

First Amendment to the Employment Agreement, dated February 16, 2022, between Lyra Therapeutics, Inc. and Maria Palasis, Ph.D (Filed With SEC on February 18, 2022)

Employment Agreement, dated February 16, 2022, between Lyra Therapeutics, Inc. and Harlan Waksal, M.D (Filed With SEC on February 18, 2022)

Lyra Therapeutics, Inc. 2020 Incentive Award Plan Performance Stock Option Grant Notice and Performance Stock Option Agreement issued to Maria Palasis, Ph.D. on February 16, 2022 (Filed With SEC on February 18, 2022)

Lyra Therapeutics, Inc. 2022 Inducement Award Plan Performance Stock Option Grant Notice and Performance Stock Option Agreement issued to Harlan Waksal, M.D. on February 16, 2022 (Filed With SEC on February 18, 2022)

Lyra Therapeutics, Inc. 2022 Inducement Award Plan (Filed With SEC on February 18, 2022)

Transition Agreement between the Registrant and R. Don Elsey dated as of September 12, 2021 (Filed With SEC on November 9, 2021)

Employment Agreement between the Registrant and Jason Cavalier dated as of September 13, 2021 (Filed With SEC on November 9, 2021)

License and Collaboration Agreement dated May 31, 2021, by and between the Registrant and LianBio Inflammatory Limited and LianBio (Filed With SEC on August 9, 2021)

Description of Securities (Filed With SEC on March 9, 2021)

Separation Agreement and Release between the Registrant and Laura Edgerly-Pflug, dated July 24, 2020 (Filed With SEC on August 5, 2020)

Form of Underwriting Agreement (Filed With SEC on April 27, 2020)

Form of Stock Certificate evidencing the shares of common stock (Filed With SEC on April 27, 2020)

Form of Warrants to Purchase Common Stock, dated various dates, issued by the Registrant to various investors, together with a schedule of warrants and warrantholders (Filed With SEC on April 27, 2020)

2020 Incentive Award Plan and form of agreements thereunder (Filed With SEC on April 27, 2020)

Non-Employee Director Compensation Program (Filed With SEC on April 27, 2020)

2020 Employee Stock Purchase Plan (Filed With SEC on April 27, 2020)

Form of Indemnification Agreement for directors and officers of the Registrant (Filed With SEC on April 27, 2020)

Employment Agreement between the Registrant and Maria Palasis, Ph.D (Filed With SEC on April 27, 2020)

Offer Letter between the Registrant and R. Don Elsey (Filed With SEC on April 27, 2020)

Offer Letter between the Registrant and Laura Edgerly-Pflug (Filed With SEC on April 27, 2020)

Eighth Amended and Restated Investor Rights Agreement, dated as of January 10, 2020 (Filed With SEC on March 6, 2020)

Form of Warrants to Purchase Common Stock, dated various dates, issued by the Registrant to various investors, together with a schedule of warrants and warrantholders (Filed With SEC on March 6, 2020)

2005 Equity Incentive Plan, as amended, and form of agreements thereunder (Filed With SEC on March 6, 2020)

2016 Equity Incentive Plan, as amended, and form of agreements thereunder (Filed With SEC on March 6, 2020)

Category

Industry

Companies

Contracts

Lyra Therapeutics, Inc. Contracts & Agreements